Search

ETH microbiologists have succeeded in showing that nature produces one of the most complex known bioactive natural products in a staggeringly simple way. The molecule originates from bacteria living in sea sponges. In future, it may be possible to produce the agent very easily using biotechnology, making it an interesting avenue for cancer research.

Incoming budget head Günther Oettinger says the research programme will receive an extra €200M – and not €400M as proposed. Top universities say this is “peanuts” next to the €2.2B taken from Horizon 2020 to fund the Juncker Plan

The UK’s exit from the EU may have bigger consequences for Ireland’s universities than counterparts in mainland Europe. Patrick Prendergast, head of Trinity College Dublin, spells out his concerns

Austrian R&I leaders offer some early principles for designing the next Framework programme.

In mapping the current political landscape, CNR offer projections on possible future orientations of the next Framework policy, suggesting innovation may come out on top.

EASSH argue for a pivot towards a more open, interdisciplinary and extended research agenda in the design of the next Framework Programme.

This wide-ranging viewpoint by Norway lays out the wishes of the government, as well as a number of Norwegian stakeholders, on the principles, priorities and structure of FP9

Science Europe provide a clear and detailed document on the European priorities and values they believe FP9 should incorporate.

Universities of Denmark outline their concerns for the design of the next Framework programme.

The EUA’s vision for the ninth Framework programme advocates enhanced University-based research as a means for addressing the challenges facing Europe.

EARTO build the case for an innovation-focussed next Framework Programme

An EESC opinion on Horizon2020 also states two views about the makeup of FP9

As the Commission gets an early start on planning its next big R&D programme, Science|Business launches a special report summarising dozens of ideas gathered at its Brussels conference

Harvard research shows people are less likely to be readmitted to hospital – and less likely to die – after treatment by female doctors

Researchers at the Medical Centre of the Gutenberg University in Mainz conducted a study to determine the extent of acceptance of web-based aftercare among patients in in-patient care.

This systematic review of PRO measurements in cancer clinical trials in Germany identified studies that use these measures and assessed the feasibility of collecting this type of patient-reported data in cancer clinical practice.

The final report of the Realising the Value programme, an 18-month programme funded by NHS England in support of its Five Year Forward View sets out ten key actions on what should be done and how people need to work differently, to put people and communities at the heart of health and wellbeing.

Researchers from the University of London, AstraZeneca and GlaxoSmithKline have developed a set of questions for practicing clinicians to consider when reviewing the results of patient-reported outcome (PROs) measures and effectiveness of medical procedures.

Research groups in Geneva and Boston surveyed 103 subjects with chronic obstructive pulmonary disease (COPD) about their preferences for using different types of electronic devices in clinical trials, including computers, internet and smartphones.